Jakobus van Ingen (Radboud University Medical Center [Radboudumc], Nijmegen, The Netherlands) shares his expert clinical perspectives on the current challenges for diagnosis and treatment of nontuberculous mycobacteria (NTM) infections and how to optimise patient management moving forward.
Questions1. How important is it to establish the underlying microbiology in nontuberculous mycobacterium (NTM) lung disease? (0:12)
2. Which microbiological tools should be used for the diagnosis of NTM lung disease? (0:58)
3. How can use of a multidisciplinary team ensure improved diagnosis and patient management in NTM lung disease? (2:17)
4. How can we improve patient outcomes in patients with NTM lung disease? (3:16)
5. What are the emerging treatment options in NTM infection? (4:55)
Speaker disclosure: Jakobus van Ingen has nothing to disclose in relation to this video interview.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018, supported by an unrestricted independent educational grant from Insmed.